Teva Announces COPAXONE Approved in Japan for Prevention of Relapse of Multiple Sclerosis

By: via Benzinga
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the approval by the Japanese Ministry of Health, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.